This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 

India’s Patent Office revokes Sutent cancer drug patent


India’s Patent Office has revoked pharmaceutical company Sugen and licensee Pfizer’s patent for the cancer drug Sutent, agreeing with Indian drugs maker Cipla that it lacks inventive step.

India, Patent Office, Pfizer, Sugen, Sutent, Cipla

More on this story

IPAB sets aside Sutent patent rejection


Payment types accepted